2013
DOI: 10.1253/circj.cj-13-0463
|View full text |Cite
|
Sign up to set email alerts
|

Left Atrial Expansion Index Predicts Atrial Fibrillation in Dyspnea

Abstract: The LA expansion index is associated with the presence of AF, and a reduced LA expansion index has a strong association with persistent AF.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
9
0
1

Year Published

2016
2016
2022
2022

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 45 publications
1
9
0
1
Order By: Relevance
“…Af was the leading predisposing factor for HFpEF events in this study. In line with our prior study [ 27 ], LAEI was an independent predictor of further occurrence of Af ( S3 Table ). Atrial fibrosis is an underlying cause of the occurrence and persistence of Af [ 28 ].…”
Section: Discussionsupporting
confidence: 91%
“…Af was the leading predisposing factor for HFpEF events in this study. In line with our prior study [ 27 ], LAEI was an independent predictor of further occurrence of Af ( S3 Table ). Atrial fibrosis is an underlying cause of the occurrence and persistence of Af [ 28 ].…”
Section: Discussionsupporting
confidence: 91%
“…LA systolic functions play a pivotal role during LV filling as suggested by the increased LA active emptying volume in patients with WCH. The LA expansion index reflects both LA stretch ability and LV filling status [27]. LA function shows a significant independent correlation with LV diastolic dysfunction, cardiac arrhythmias, and arterial stiffness in most categories of patients compared with LA volume [28].…”
Section: Discussionmentioning
confidence: 98%
“…On a population level, one SD decrement (11 ml/m 2 ) in RVEDVI has been associated with a 12% increase in the risk of dyspnea after adjustment for spirometric measurements and CT-defined emphysema (15). Furthermore, increases in cardiac output are associated with improvements in walking intensity across all severities of COPD, whereas reduced atrial EF, independent of atrial size, predicts the development of atrial fibrillation in patients with dyspnea (16)(17)(18). The ability to modify cardiac morphology and function does therefore seem to independently impact on relevant clinical and patientcentered outcomes, and highlights the importance of identifying and optimally treating this "lung-deflator" clinical phenotype (19).…”
Section: Discussionmentioning
confidence: 99%